fremanezumab
FDA Approves Ajovy for Migraine Prevention
The FDA approved Ajovy, a humanized monoclonal antibody, for the prevention of migraine in adults.
SEPTEMBER 18, 2018

Fremanezumab for Migraine Shows Impressive Results
Subcutaneous injections of the experimental migraine drug fremanezumab at monthly or quarterly intervals provided ...
NOVEMBER 27, 2017

Load more